https://www.marketscreener.com/quote/stock/PFIZER-INC-23365019/news/Pfizer-Inc-TIVDAK-Supplemental-Biologics-License-Application-Accepted-for-Priority-Review-by-U-S-45713816/?utm_source=telegram&utm_medium=social&utm_campaign=share